NFlection Therapeutics

Boston, MA · Founded 2014 · Privately Held (backing)

Developer of topical therapies designed to address rare skin disorders associated with abnormal RAS pathway activity. NFlection Therapeutics is based in Boston, MA and was founded in 2014. It was valued at $156 million at its later-stage round in Aug 2025, the last priced event on record. It has raised $65.5 million across 3 recorded rounds; the latest was a $4 million seed round in Jul 2023.

PMV mark · valuation
$156.0M
Oct 2026
Priced at
its later-stage round
Aug 2025
Total raised
$65.5M
Last round
Seed Round
Jul 2023

Who backs NFlection Therapeutics?

5 investors
InvestorType
F-Prime CapitalVenture capital
Eight RoadsAsset manager
venBioVenture capital
Children's Tumor Foundation—
U.S. Department of Health and Human Services—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

NFlection Therapeutics investors

5 investors are on record for NFlection Therapeutics, including F-Prime Capital, Eight Roads, venBio and Children's Tumor Foundation. The seed round in Jul 2023 drew 2 investors.

Free account
More of NFlection Therapeutics with a free account
  • ·Watch NFlection Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 5 firms already write checks for companies like NFlection Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View